BIOVIA provides a scientific collaborative environment for advanced biological, chemical and materials experiences that allows science-driven companies access, organize, analyze and share data in unprecedented ways throughout the product lifecycle in regulated and non-regulated environments. BIOVIA’s sophisticated enterprise portfolio of Scientific Informatics, Molecular Modeling & Simulation, Data Science, Laboratory Informatics, Formulation Design, Quality & Compliance and Manufacturing Analytics helps drive innovation, increase productivity, improve quality and compliance, reduce costs and accelerate time to market.
With 3DEXPERIENCE R2020x, users across the industries served by Dassault Systèmes benefit from new and enhanced roles in the BIOVIA's extensive portfolio.
Dassault Systèmes helps BioPharmaceutical companies achieving Quality and Business Excellence with a new a comprehensive data-centric approach to Quality.
R&D organizations must ensure that researchers have the tools that support their work via data-driven decisions.
Modeling & Simulation provides a snapshot of the fundamental atomic interactions supporting product performance.
Democratizing data science helps teams do more with less and unlock the innovations that today's businesses need to survive and thrive.
Digital Laboratory Informatics capabilities allow for compliant and efficient lab workflows, harmonization and standardization.
BIOVIA helps accelerate product innovation and product launches while successfully navigating complex regulatory requirements.
Operations can leverage process and quality data to optimize and control product quality, variability and yield.
Rely on BIOVIA as you trusted partner to meet regulatory requirements
According to GAMP 5 Software Categories, BIOVIA’s solutions fall under the category 4, configurable software. BIOVIA’s solutions are designed to enable compliance with different regulations like US FDA 21 CFR Part 11 and EU Annex 11.
Download the BIOVIA Quality Statement here to see a high level overview of our approach to Quality.
Regulatory checklists for risk assessment and reduction of validation efforts are available on request.
